Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
DoubleJump Interchange is a collaborative platform hosted in the cloud that seamlessly merges data from both clinical and real-world environments to enhance cooperation between researchers and healthcare practitioners, ultimately aiming to improve the health of consumers. Consumers, along with their extended care teams, benefit from a diverse array of health information sourced from hospitals, clinics, and remote monitoring technologies, enabling them to engage in personalized, socially supported, and timely disease prevention and management. Researchers are provided with a rich pool of clinical, molecular, and real-world data, facilitating the discovery of new disease targets and identifying biomarkers that predict treatment responses effectively. By sharing clinical expertise throughout a network of healthcare providers, the platform strives to advance the principles of precision medicine. Furthermore, it accelerates the accessibility of intricate data sets, thereby driving innovation in both translational research and healthcare delivery processes. This interconnected approach not only enhances collaboration but also supports the overarching goal of elevating overall consumer health outcomes.
Description
Specialty and rare diseases often encompass patient populations that are not clearly defined, including individuals who remain undiagnosed or face misdiagnoses, along with healthcare providers who may lack knowledge about these conditions and their various manifestations, resulting in treatment pathways that are poorly understood. IPM.ai operates as an Insights-as-a-Service (IaaS) firm, dedicated to empowering leading life sciences organizations to gain deeper insights into patient care and enhance the quality of life for those affected through the development, clinical research, and commercialization of therapeutic solutions. By predicting market size, analyzing the competitive landscape, and estimating potential return on investment, companies can optimize their commercialization strategies. Additionally, the platform identifies undiagnosed and misdiagnosed individuals who could benefit from early disease interception and therapeutic measures. It employs statistical models to gauge the prevalence of specific diseases within certain patient populations at any given moment. Furthermore, IPM.ai helps pinpoint physicians who are adept at diagnosing and treating these ideal patients, while also influencing other healthcare providers to enhance overall patient outcomes. This comprehensive approach ultimately aims to bridge the gap in understanding and addressing the needs of those with rare diseases.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
PwC
Founded
1998
Country
United Kingdom
Website
www.pwc.com/us/en/products/double-jump.html
Vendor Details
Company Name
IPM.ai
Country
United States
Website
www.ipm.ai/platform